AXQ Capital’s Voyager Therapeutics VYGR Stock Holding History

AXQ Capital’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-27,360	Closed	-$128K	–	947
2025 Q3	$128K	Buy	27,360 +8,844	+48%	+$32K	0.05%	496
2025 Q2	$57.6K	Buy	+18,516	New	+$59.7K	0.02%	536

Other funds holding VYGR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AXQ Capital's VYGR Position: Q4 2025 in Review

AXQ Capital sold out of Voyager Therapeutics (VYGR) in Q4 2025, closing a stake of 27,360 shares — an estimated $128K sold.

AXQ Capital first reported a position in VYGR in Q2 2025 and held it in 2 quarters. The position peaked at $128K in Q3 2025. 125 funds tracked by Wall St. Rank hold VYGR as of Q4 2025.

AXQ Capital reported no remaining Voyager Therapeutics position as of Q4 2025 after selling out during the quarter.
AXQ Capital sold 27,360 Voyager Therapeutics shares in Q4 2025, an estimated $128K.
AXQ Capital first reported a position in Voyager Therapeutics in Q2 2025 and held it in 2 quarters.
AXQ Capital's Voyager Therapeutics position peaked at $128K in Q3 2025.
125 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2025.

Based on AXQ Capital's 13F filing for Q4 2025, filed 10 Feb 2026.